{
    "clinical_study": {
        "@rank": "117698", 
        "acronym": "GRICS II", 
        "arm_group": [
            {
                "arm_group_label": "Standard group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Goal-directed therapy (GDT) protocol", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether a goal-directed resuscitation therapy\n      within the first 8 hours after major abdominal cancer surgery reduces postoperative\n      complications compared to a standard therapy."
        }, 
        "brief_title": "Goal-Directed Therapy in Cancer Surgery", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Care", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients admitted to ICU in immediate postoperatory of major abdominal surgery for\n             cancer treatment\n\n          -  Age over 18 years-old\n\n        Exclusion Criteria:\n\n          -  Weight under 55 kilograms or over 140 kilograms;\n\n          -  Contra-indication for invasive hemodynamic monitoring;\n\n          -  Expected ICU permanence less than 24 hours;\n\n          -  Active bleeding\n\n          -  Vasoplegic shock with noradrenaline dose higher than 1mcg/kg/min\n\n          -  Enrolled in other study\n\n          -  Refuse to consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946269", 
            "org_study_id": "GRICS-02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Goal-directed therapy (GDT) protocol", 
                "description": "A target value of a cardiac index (CI) greater than 2.5 L/min/m2 and a mean arterial pressure of 70 mmHg will be sought.\nThe first step will be fluid resuscitation with 200ml aliquots of Lactated Ringer's solution plus human albumin 20% 50 mL whenever the CI is lower than 2.5 L/min/m2. The fluid challenge will be stopped if the CVP rises by more than 4 mmHg during the infusion period or CI increases less than 10%.\nWhen the CI is lower than or equal to 2.5L/min/m2 despite of fluid challenge, dobutamine will be initiated with increasing doses up to 20mcg/kg/min.\nThe final step will be red blood transfusion to reach a hematocrit higher than 28%.\nIf necessary, norepinephrine infusion will be used to maintain a mean arterial pressure above 70 mmHg.", 
                "intervention_name": "Goal-directed Resuscitation Therapy (GDT)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Standard group", 
                "description": "The control group will be managed by the surgical ICU staff in the postoperative period according to institutional protocol of hemodynamic monitoring.", 
                "intervention_name": "Standard protocol", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 18, 2013", 
        "location": {
            "contact": {
                "email": "dra.alinemuller@gmail.com", 
                "last_name": "Aline M\u00fcller, MD", 
                "phone": "55-11-974130225"
            }, 
            "facility": {
                "address": {
                    "city": "Sao Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "01246000"
                }, 
                "name": "Intensive Care Unit of the Cancer Institute of Sao Paulo State"
            }, 
            "investigator": [
                {
                    "last_name": "Aline M\u00fcller, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ludhmila Hajjar, MD, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Goal-directed Resuscitation in High-risk Patients Undergoing Major Cancer Surgery: a Controlled and Randomized Study", 
        "overall_contact": {
            "email": "dra.alinemuller@gmail.com", 
            "last_name": "Aline M\u00fcller, MD", 
            "phone": "55-11-974130225"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Death or one of the following complications: stroke, renal failure, respiratory complications, cardiovascular complications, deep wound infection and reoperation for any reason.", 
            "measure": "Composite endpoint of death or major postoperative complications", 
            "safety_issue": "Yes", 
            "time_frame": "30 days after randomization"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946269"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo", 
            "investigator_full_name": "Ludhmila Abrah\u00e3o Hajjar", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To compare the number of days of ICU stay and hospital stay between groups.", 
                "measure": "Duration of ICU stay and hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "To compare levels of DO2, lactate, ScvO2, base excess and venous to arterial carbon dioxide difference between groups.", 
                "measure": "Tissue hypoperfusion markers", 
                "safety_issue": "Yes", 
                "time_frame": "7 days after randomization"
            }, 
            {
                "description": "Daily sequential organ failure assessment score within the first 7 days after randomization", 
                "measure": "Daily SOFA score", 
                "safety_issue": "Yes", 
                "time_frame": "7 days after randomization"
            }, 
            {
                "description": "To compare the incidence of cardiovascular complications between groups. Cardiovascular complications will be defined as myocardial ischemia, acute decompensated heart failure, mesenteric ischemia, pulmonary thromboembolism and peripheral vascular ischemia.", 
                "measure": "Cardiovascular complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "Respiratory complication will be defined as acute distress respiratory syndrome according to Berlin criteria", 
                "measure": "Respiratory complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "Severe renal complication will be defined as renal failure according to Acute Kidney Injury Network (AKIN) stage 3.", 
                "measure": "Severe Renal complication", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "To compare the incidence of stroke between groups within 30 days after randomization.", 
                "measure": "Neurological complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "To compare the incidence, between groups, of infectious complications defined as a new septic shock.", 
                "measure": "Severe infectious complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }, 
            {
                "description": "To compare the incidence between groups of surgical complication. Surgical complication will be defined as reoperation due to any reason, hospital readmission or death", 
                "measure": "Surgical complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after randomization"
            }
        ], 
        "source": "University of Sao Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}